Yi Wang

Position: Partner, Head of Capital Markets Group

Office: Shanghai

Professional Experience & Core Expertise: Mr. Wang has been practicing for more than 20 years with leading PRC firms and international firms in Beijing, Hong Kong, and Shanghai. He specializes in a wide range of domestic and overseas listings, bond and stock issuances, M&A of listed companies, and private equity fund formation and investments.

Professional Qualifications: PRC Bar Qualification；LL.M. from University of California, Berkeley

Institutional Roles (more details): Mr. Wang currently serves as a director for several listed companies, insurance companies, private equity funds, and other financial institutions. Previously served as an Independent Director of Jinhong Fashion Group Co., Ltd. (May 31, 2016 - June 5, 2019).

PE/VC Funds: Sequoia Capital, China Everbright, PAG, CCB International, CITIC Capital, Hillhouse Capital, Advent International, Warburg Pincus, CDH Investments, FountainVest Partners, etc.

Mr. Wang Yi currently serves on several key internal committees at JunHe LLP, holding leadership roles that reflect his commitment to the firm's governance and development:

Member of the Strategic Development Committee: Participates in the firm's strategic planning and development discussions, analyzing market trends and industry changes to provide strategic recommendations that ensure JunHe's sustainable growth and competitive advantage.

Chair/Convener of the Review Committee: Oversees the recruitment process for external partners and the performance evaluation of internal partners, ensuring all partners meet JunHe's standards and expectations.

Member of the Professional Development Committee: Provides training, guidance, and support to associates, ensuring clear and reasonable career development paths and facilitating both personal and professional growth.

Member of the Internal Review Committee: Serves as a risk management and compliance guardian for JunHe's securities practice, identifying and assessing potential risks, and ensuring compliance with laws, regulations, and industry standards to safeguard the firm's reputation and professionalism.

2019 – Harbin Pharmaceutical's US$300 Million Investment in GNC

As the lead partner and exclusive PRC legal advisor to Harbin Pharmaceutical Co., Ltd. (600664), Mr. Wang advised on its US$299.95 million subscription of convertible preferred shares of NYSE-listed GNC Holdings, Inc. (NYSE:GNC). Upon conversion, Harbin Pharmaceutical became GNC's single largest shareholder with a 40.1% equity interest. This cross-border strategic investment, completed against the backdrop of the China-US trade war, involved two dual-listed companies and lasted over one year.

2020 – First WVR IPO on A-Share Market – UCloud

Mr. Wang served as the lead partner for the issuer, assisting UCloud Technology Co., Ltd. in its successful listing on the STAR Market of the Shanghai Stock Exchange, setting a precedent as the first weighted voting rights (WVR) IPO on the A-share market.

2023 – Canadian Solar (CSI Solar) – STAR Market Spin-off IPO

Mr. Wang acted as the lead partner and issuer's counsel for CSI Solar's A-share IPO on the STAR Market (Stock Code: 688472). CSI Solar was spun off from its NASDAQ-listed parent, Canadian Solar Inc. (CSIQ), representing the largest spin-off IPO financing project since the full implementation of the registration-based IPO system in 2023, with total proceeds of approximately RMB 6 billion.

2025 – WeRide Inc. – Dual Primary Listing on HKEX

As the lead partner of JunHe's New York office, Mr. Wang acted as the Company's U.S. counsel for WeRide's HKEX listing (Stock Code: 0800.HK). WeRide became the world's first autonomous driving company to achieve dual-primary listings on both NASDAQ (2024) and HKEX (2025).

2025 – Fibocom Wireless Inc. – A+H Dual Listing on HKEX

Mr. Wang served as the lead partner and PRC legal advisor to the sole sponsor and underwriters for Fibocom's H-share listing on HKEX (Stock Code: 0638.HK). Fibocom, already listed on Shenzhen ChiNext Board (Stock Code: 300638), successfully achieved A+H dual listing with total proceeds of approximately HK$2.9 billion.

2026 – Qiming Venture Partners – Acquisition of A-Share Listed Tianmai Technology

Mr. Wang served as the lead partner and exclusive legal advisor to Qiming Venture Partners' M&A fund in its acquisition of control of Shenzhen-listed Tianmai Technology (Stock Code: 300807). This was the first market-announced private equity fund acquisition of a listed company following the CSRC's "M&A Six Measures" (2024).

Mr. Wang joined JunHe LLP in 2004 and has been practicing for more than 20 years. He is currently a Partner in the Capital Markets Department and the Head of the Capital Markets Group. Prior to joining JunHe, he worked with leading PRC and international law firms in Beijing, Hong Kong, and Shanghai, which provided him with valuable cross-border and cross-jurisdictional experience. He was promoted to Partner at JunHe in 2010. His career milestones include leading the first WVR IPO on the A-share market (UCloud) in 2020, serving as the lead partner for the largest spin-off IPO since the full implementation of the registration-based IPO system (CSI Solar) in 2023, and advising on the world's first dual-primary listing of an autonomous driving company (WeRide) in 2025. In 2022, he was recognized by ALB as one of the "Asia Super 50 T Lawyers." Throughout his career, he has consistently been ranked as a leading lawyer in Capital Markets by Chambers and Partners (2013-2025) and in TMT by The Legal 500.

Fudan University

Bachelor

1997 - 2001

UC Berkeley

LLM

2017 - 2018

Leading Partner: Capital Markets; TMT; Corporate & M&A; Private Equity

The Legal 500 Asia-Pacific

2026

Ranked Lawyer: Capital Markets: Debt & Equity (Band 3)

Chambers Greater China Region

2026

Leading Partner: Capital Markets

The Legal 500 Asia-Pacific

2025

IFLR1000 China Awards – Annual Transaction: Shanghai – Capital Markets (Atour NASDAQ Listing) – Lead Partner

IFLR1000

2023

China Dealmaker of ASIA

ALB

2022

China Top 15 TMT Lawyers

ALB

2021